{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:31:09Z","timestamp":1794666669082,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of the study was to measure the hepcidin concentration and evaluate Fe homeostasis indices in a prospective study on patients with newly diagnosed hypothyroidism in the course of Hashimoto\u2019s thyroiditis (HT) and following successful therapy. The prospective observational study consisted of 34 patients. The clinical evaluation and laboratory tests were performed at diagnosis (T0) and after restoration of euthyreosis 12 weeks later (T1). The median level of hepcidin was significantly lower (p\u2009=\u20090.002) after recovery (7.7 [6.2\u201313.0] ng\/mL) than that before treatment (17.4 [7.6\u201320.4] ng\/mL), while creatinine (p\u2009=\u20090.011) and GFR (p\u2009&lt;\u20090.001) significantly improved after euthyroidism was achieved. A positive correlation was observed between hepcidin and fT3 (p\u2009=\u20090.033, r\u2009=\u20090.465) at T0. In the females, the level of hepcidin positively correlated with ferritin concentration before (p\u2009&lt;\u20090.001, r\u2009=\u20090.928) and after treatment (p\u2009&lt;\u20090.001, r\u2009=\u20090.835). A statistically significant difference was observed in RDW-CV (red blood cell distribution width - coefficient of variation) between the hypothyroid and euthyroid states. In conclusion, a decrease in hepcidin concentration during the transition from the hypothyroid state to euthyroidism in patients with HT is associated with the observed dynamics in iron homeostasis, mainly reflected by improvement in RDW-CV and significant correlations between ferritin and hepcidin as well as between hepcidin and fT3.<\/jats:p>","DOI":"10.1038\/s41598-019-52715-3","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T11:05:29Z","timestamp":1573124729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The hepcidin concentration decreases in hypothyroid patients with Hashimoto\u2019s thyroiditis following restoration of euthyroidism"],"prefix":"10.1038","volume":"9","author":[{"given":"Aleksandra","family":"Hernik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-3274","authenticated-orcid":false,"given":"Ewelina","family":"Szczepanek-Parulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-4558","authenticated-orcid":false,"given":"Dorota","family":"Filipowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abdolall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4824-8131","authenticated-orcid":false,"given":"Martyna","family":"Borowczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wrotkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Czarnywojtek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Krasi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"52715_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.20452\/pamw.3985","volume":"127","author":"E Szczepanek-Parulska","year":"2017","unstructured":"Szczepanek-Parulska, E., Hernik, A. & Ruchala, M. Anemia in thyroid diseases. Pol Arch Intern Med 127, 352\u2013360, https:\/\/doi.org\/10.20452\/pamw.3985 (2017).","journal-title":"Pol Arch Intern Med"},{"key":"52715_CR2","first-page":"136","volume":"52","author":"N Antonijevic","year":"1999","unstructured":"Antonijevic, N., Nesovic, M., Trbojevic, B. & Milosevic, R. Anemia in hypothyroidism. Med Pregl 52, 136\u2013140 (1999).","journal-title":"Med Pregl"},{"key":"52715_CR3","first-page":"29","volume":"91","author":"TA Nekrasova","year":"2013","unstructured":"Nekrasova, T. A., Strongin, L. G. & Ledentsova, O. V. Hematological disturbances in subclinical hypothyroidism and their dynamics during substitution therapy. Klin Med (Mosk) 91, 29\u201333 (2013).","journal-title":"Klin Med (Mosk)"},{"key":"52715_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/cen.12994","volume":"84","author":"K M\u2019Rabet-Bensalah","year":"2016","unstructured":"M\u2019Rabet-Bensalah, K. et al. Thyroid dysfunction and anaemia in a large population-based study. Clin Endocrinol (Oxf) 84, 627\u2013631, https:\/\/doi.org\/10.1111\/cen.12994 (2016).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"52715_CR5","first-page":"272","volume":"22","author":"J Fandrey","year":"1994","unstructured":"Fandrey, J., Pagel, H., Frede, S., Wolff, M. & Jelkmann, W. Thyroid hormones enhance hypoxia-induced erythropoietin production in vitro. Exp Hematol 22, 272\u2013277 (1994).","journal-title":"Exp Hematol"},{"key":"52715_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2141.1977.tb06833.x","volume":"37","author":"DW Golde","year":"1977","unstructured":"Golde, D. W., Bersch, N., Chopra, I. J. & Cline, M. J. Thyroid hormones stimulate erythropoiesis in vitro. Br J Haematol 37, 173\u2013177 (1977).","journal-title":"Br J Haematol"},{"key":"52715_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.aprim.2010.03.016","volume":"43","author":"P Dominguez Ruiz de Leon","year":"2011","unstructured":"Dominguez Ruiz de Leon, P. et al. Macrocytosis without anaemia in an urban population. Aten Primaria 43, 183\u2013189, https:\/\/doi.org\/10.1016\/j.aprim.2010.03.016 (2011).","journal-title":"Aten Primaria"},{"key":"52715_CR8","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.4103\/2230-8210.104093","volume":"16","author":"C Das","year":"2012","unstructured":"Das, C. et al. Etiology of anemia in primary hypothyroid subjects in a tertiary care center in Eastern India. Indian J Endocrinol Metab 16, S361\u2013363, https:\/\/doi.org\/10.4103\/2230-8210.104093 (2012).","journal-title":"Indian J Endocrinol Metab"},{"key":"52715_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/jn\/132.7.1951","volume":"132","author":"SY Hess","year":"2002","unstructured":"Hess, S. Y., Zimmermann, M. B., Arnold, M., Langhans, W. & Hurrell, R. F. Iron deficiency anemia reduces thyroid peroxidase activity in rats. J Nutr 132, 1951\u20131955, https:\/\/doi.org\/10.1093\/jn\/132.7.1951 (2002).","journal-title":"J Nutr"},{"key":"52715_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/105072502761016494","volume":"12","author":"MB Zimmermann","year":"2002","unstructured":"Zimmermann, M. B. & Kohrle, J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 12, 867\u2013878, https:\/\/doi.org\/10.1089\/105072502761016494 (2002).","journal-title":"Thyroid"},{"key":"52715_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","volume":"480","author":"A Krause","year":"2000","unstructured":"Krause, A. et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147\u2013150 (2000).","journal-title":"FEBS Lett"},{"key":"52715_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tips.2014.01.004","volume":"35","author":"P Ruchala","year":"2014","unstructured":"Ruchala, P. & Nemeth, E. The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci 35, 155\u2013161, https:\/\/doi.org\/10.1016\/j.tips.2014.01.004 (2014).","journal-title":"Trends Pharmacol Sci"},{"key":"52715_CR13","doi-asserted-by":"publisher","unstructured":"Rishi, G., Wallace, D. F. & Subramaniam, V. N. Hepcidin: regulation of the master iron regulator. Biosci Rep 35\n                           https:\/\/doi.org\/10.1042\/BSR20150014 (2015).","DOI":"10.1042\/BSR20150014"},{"key":"52715_CR14","doi-asserted-by":"publisher","first-page":"5184354","DOI":"10.1155\/2018\/5184354","volume":"2018","author":"E Rusak","year":"2018","unstructured":"Rusak, E. et al. Markers of Anemia in Children with Type 1 Diabetes. J Diabetes Res 2018, 5184354, https:\/\/doi.org\/10.1155\/2018\/5184354 (2018).","journal-title":"J Diabetes Res"},{"key":"52715_CR15","first-page":"2001","volume":"60","author":"VE Manolov","year":"2014","unstructured":"Manolov, V. E., Atanasova, B. D., Velizarova, M. G., Vasilev, V. G. & Tzatchev, K. N. Serum hepcidin levels in Bulgarian population. Clin Lab 60, 2001\u20132006 (2014).","journal-title":"Clin Lab"},{"key":"52715_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001216","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Bhatia, P., Jain, R. & Bharti, B. Plasma Hepcidin Levels in Healthy Children: Review of Current Literature Highlights Limited Studies. J Pediatr Hematol Oncol. https:\/\/doi.org\/10.1097\/MPH.0000000000001216 (2018).","journal-title":"J Pediatr Hematol Oncol"},{"key":"52715_CR17","first-page":"73","volume":"3","author":"A Dorgalaleh","year":"2013","unstructured":"Dorgalaleh, A. et al. Effect of thyroid dysfunctions on blood cell count and red blood cell indice. Iran J Ped Hematol Oncol 3, 73\u201377 (2013).","journal-title":"Iran J Ped Hematol Oncol"},{"key":"52715_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1182\/blood.V45.5.671.671","volume":"45","author":"LA Malgor","year":"1975","unstructured":"Malgor, L. A. et al. Direct effects of thyroid hormones on bone marrow erythroid cells of rats. Blood 45, 671\u2013679 (1975).","journal-title":"Blood"},{"key":"52715_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1210\/jcem-40-2-211","volume":"40","author":"KC Das","year":"1975","unstructured":"Das, K. C., Mukherjee, M., Sarkar, T. K., Dash, R. J. & Rastogi, G. K. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 40, 211\u2013220, https:\/\/doi.org\/10.1210\/jcem-40-2-211 (1975).","journal-title":"J Clin Endocrinol Metab"},{"key":"52715_CR20","first-page":"375","volume":"111","author":"RA Savage","year":"1987","unstructured":"Savage, R. A. & Sipple, C. Marrow myxedema. Gelatinous transformation of marrow ground substance in a patient with severe hypothyroidism. Arch Pathol Lab Med 111, 375\u2013377 (1987).","journal-title":"Arch Pathol Lab Med"},{"key":"52715_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1055\/s-0034-1383564","volume":"122","author":"G Aktas","year":"2014","unstructured":"Aktas, G. et al. Could red cell distribution width be a marker in Hashimoto\u2019s thyroiditis? Exp Clin Endocrinol Diabetes 122, 572\u2013574, https:\/\/doi.org\/10.1055\/s-0034-1383564 (2014).","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"52715_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5603\/EP.a2018.0018","volume":"69","author":"A Czarnywojtek","year":"2018","unstructured":"Czarnywojtek, A. et al. Red cell distribution width - a new marker for exacerbation of heart failure in patients with hypothyroidism following radioiodine therapy. Endokrynol Pol 69, 235\u2013240, https:\/\/doi.org\/10.5603\/EP.a2018.0018 (2018).","journal-title":"Endokrynol Pol"},{"key":"52715_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1751-553X.2008.01082.x","volume":"31","author":"M Montagnana","year":"2009","unstructured":"Montagnana, M., Lippi, G., Targher, G., Salvagno, G. L. & Guidi, G. C. The red blood cell distribution width is associated with serum levels of thyroid stimulating hormone in the general population. Int J Lab Hematol 31, 581\u2013582, https:\/\/doi.org\/10.1111\/j.1751-553X.2008.01082.x (2009).","journal-title":"Int J Lab Hematol"},{"issue":"Suppl 1","key":"52715_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0736-4679(91)90592-4","volume":"9","author":"TC Evans","year":"1991","unstructured":"Evans, T. C. & Jehle, D. The red blood cell distribution width. J Emerg Med 9(Suppl 1), 71\u201374 (1991).","journal-title":"J Emerg Med"},{"key":"52715_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1590\/0004-2730000002836","volume":"58","author":"HM Yu","year":"2014","unstructured":"Yu, H. M., Park, K. S. & Lee, J. M. The value of red blood cell distribution width in subclinical hypothyroidism. Arq Bras Endocrinol Metabol 58, 30\u201336 (2014).","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"52715_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.14310\/horm.2002.11105","volume":"2","author":"M Christ-Crain","year":"2003","unstructured":"Christ-Crain, M. et al. Effect of restoration of euthyroidism on peripheral blood cells and erythropoietin in women with subclinical hypothyroidism. Hormones (Athens) 2, 237\u2013242 (2003).","journal-title":"Hormones (Athens)"},{"key":"52715_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3181\/00379727-201-43507","volume":"201","author":"PS Sullivan","year":"1992","unstructured":"Sullivan, P. S. & McDonald, T. P. Thyroxine suppresses thrombocytopoiesis and stimulates erythropoiesis in mice. Proc Soc Exp Biol Med 201, 271\u2013277 (1992).","journal-title":"Proc Soc Exp Biol Med"},{"key":"52715_CR28","first-page":"101","volume":"45","author":"L Horton","year":"1976","unstructured":"Horton, L., Coburn, R. J., England, J. M. & Himsworth, R. L. The haematology of hypothyroidism. Q J Med 45, 101\u2013123 (1976).","journal-title":"Q J Med"},{"key":"52715_CR29","doi-asserted-by":"publisher","first-page":"e0148802","DOI":"10.1371\/journal.pone.0148802","volume":"11","author":"M Lehtihet","year":"2016","unstructured":"Lehtihet, M. et al. Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans. PLoS One 11, e0148802, https:\/\/doi.org\/10.1371\/journal.pone.0148802 (2016).","journal-title":"PLoS One"},{"key":"52715_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/cen.13450","volume":"87","author":"S Fischli","year":"2017","unstructured":"Fischli, S. et al. Iron metabolism in patients with Graves\u2019 hyperthyroidism. Clin Endocrinol (Oxf) 87, 609\u2013616, https:\/\/doi.org\/10.1111\/cen.13450 (2017).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"52715_CR31","doi-asserted-by":"publisher","first-page":"5764061","DOI":"10.1155\/2019\/5764061","volume":"2019","author":"A Hernik","year":"2019","unstructured":"Hernik, A. et al. Hepcidin and Iron Homeostasis in Patients with Subacute Thyroiditis and Healthy Subjects. Mediators Inflamm 2019, 5764061, https:\/\/doi.org\/10.1155\/2019\/5764061 (2019).","journal-title":"Mediators Inflamm"},{"key":"52715_CR32","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1210\/jc.2010-0864","volume":"95","author":"E Bachman","year":"2010","unstructured":"Bachman, E. et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 95, 4743\u20134747, https:\/\/doi.org\/10.1210\/jc.2010-0864 (2010).","journal-title":"J Clin Endocrinol Metab"},{"key":"52715_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/acel.12052","volume":"12","author":"W Guo","year":"2013","unstructured":"Guo, W. et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 12, 280\u2013291, https:\/\/doi.org\/10.1111\/acel.12052 (2013).","journal-title":"Aging Cell"},{"key":"52715_CR34","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1210\/en.2011-2045","volume":"153","author":"Q Yang","year":"2012","unstructured":"Yang, Q., Jian, J., Katz, S., Abramson, S. B. & Huang, X. 17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 153, 3170\u20133178, https:\/\/doi.org\/10.1210\/en.2011-2045 (2012).","journal-title":"Endocrinology"},{"key":"52715_CR35","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","volume":"117","author":"TE Galesloot","year":"2011","unstructured":"Galesloot, T. E. et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 117, e218\u2013225, https:\/\/doi.org\/10.1182\/blood-2011-02-337907 (2011).","journal-title":"Blood"},{"key":"52715_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/08860220500243338","volume":"27","author":"M Suher","year":"2005","unstructured":"Suher, M., Koc, E., Ata, N. & Ensari, C. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail 27, 739\u2013742 (2005).","journal-title":"Ren Fail"},{"key":"52715_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-2265.2005.02236.x","volume":"62","author":"JG den Hollander","year":"2005","unstructured":"den Hollander, J. G., Wulkan, R. W., Mantel, M. J. & Berghout, A. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf) 62, 423\u2013427, https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02236.x (2005).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"52715_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41390-018-0005-0","volume":"84","author":"H Moran-Lev","year":"2018","unstructured":"Moran-Lev, H. et al. The interrelationship between hepcidin, vitamin D, and anemia in children with acute infectious disease. Pediatr Res 84, 62\u201365, https:\/\/doi.org\/10.1038\/s41390-018-0005-0 (2018).","journal-title":"Pediatr Res"},{"key":"52715_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2253-0","volume":"22","author":"S Lasocki","year":"2018","unstructured":"Lasocki, S. et al. Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients. Crit Care 22, 314, https:\/\/doi.org\/10.1186\/s13054-018-2253-0 (2018).","journal-title":"Crit Care"},{"key":"52715_CR40","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.3892\/ol.2018.9459","volume":"16","author":"K Brzoska","year":"2018","unstructured":"Brzoska, K. et al. Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer. Oncol Lett 16, 6831\u20136837, https:\/\/doi.org\/10.3892\/ol.2018.9459 (2018).","journal-title":"Oncol Lett"},{"key":"52715_CR41","doi-asserted-by":"crossref","unstructured":"Prikryl, P. et al. Serum hepcidin is increased in ANCA-associated vasculitis and correlates with activity markers. Physiol Res (2018).","DOI":"10.33549\/physiolres.933765"},{"key":"52715_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12291-017-0702-1","volume":"33","author":"N Kunireddy","year":"2018","unstructured":"Kunireddy, N. et al. Hepcidin and Ferritin: Important Mediators in Inflammation Associated Anemia in Systemic Lupus Erythematosus Patients. Indian J Clin Biochem 33, 406\u2013413, https:\/\/doi.org\/10.1007\/s12291-017-0702-1 (2018).","journal-title":"Indian J Clin Biochem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52715-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52715-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52715-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:31:38Z","timestamp":1671291098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52715-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52715"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52715-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16222"}}